Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Deferred Tax Asset [Domain] Deferred Tax Asset [Domain] Performance stock units issued and outstanding (unvested) under the 2020 Plan (in shares) Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Performance Stock Units Available For Future Grant Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Performance Stock Units Available For Future Grant Remaining useful life (in years) Intangible Asset, Finite-Lived, Remaining Amortization Period Trading Arrangement: Trading Arrangement [Axis] Agent fee (as a percent) Sale of Stock, Sales Agent Fee, Percentage Of Gross Proceeds Sale of Stock, Sales Agent Fee, Percentage Of Gross Proceeds Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Title of 12(b) Security Title of 12(b) Security Subsequent Event Subsequent Event [Member] Debt Securities, Available-for-Sale [Table] Debt Securities, Available-for-Sale [Table] Document Fiscal Year Focus Document Fiscal Year Focus Business Combination, Contingent Consideration, Triggering Event [Domain] Business Combination, Contingent Consideration, Triggering Event [Domain] Business Combination, Contingent Consideration, Triggering Event [Domain] Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Number of Shares Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Customer [Axis] Customer [Axis] Segment Reporting [Abstract] Purchase Agreement Purchase Agreement [Member] Purchase Agreement Schedule of Expected Future Amortization Expense Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense [Table Text Block] Common stock, $0.0001 par value; 200,000,000 shares authorized; 43,271,347 shares issued and outstanding at June 30, 2026 (unaudited); 42,553,931 shares issued and outstanding at December 31, 2025 Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Schedule of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Accrued payroll and benefits Employee-related Liabilities, Current Maximum milestone payments Collaborative Arrangement, Maximum Milestone Payment Collaborative Arrangement, Maximum Milestone Payment Service condition period for full vesting (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Line of Credit Line of Credit [Member] Restatement Determination Date Restatement Determination Date Tenant improvement allowance Lessee, Tenant Improvement Allowance Lessee, Tenant Improvement Allowance Pre-funded warrants to purchase common stock (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Amendment Flag Amendment Flag Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Inventory, non-current Inventory, non-current Inventory, Noncurrent Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax 2016 Plan Equity Incentive Plan 2016 [Member] Equity Incentive Plan 2016 RELATED PARTY TRANSACTION Related Party Transactions Disclosure [Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Preferred stock purchased Payments to Acquire Equity Securities, FV-NI Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Cash equivalents: Cash and Cash Equivalents [Abstract] Intangible assets, net Intangible assets, net Intangible Asset, Excluding Goodwill, after Accumulated Amortization Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted-average shares outstanding, basic (in shares) Weighted-average shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Net amortization/accretion of marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Long-term investments Long-Term Investments Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Work in progress Inventory, Work in Process, Net of Reserves Raw materials Inventory, Raw Materials, Noncurrent, Net of Reserves Inventory, Raw Materials, Noncurrent, Net of Reserves Entity Address, City or Town Entity Address, City or Town Non-cash lease expense Operating Lease, Noncash Expense Operating Lease, Noncash Expense Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Product sales, net Product sales, net Product [Member] Royalty expense Royalty Expense Total future amortization Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Anterior In-License Agreement Anterior In-License Agreement [Member] Anterior In-License Agreement Proceeds from sale of common stock under employee stock purchase plan Proceeds from Stock Plans Unrealized gains Cash And Cash Equivalents, Accumulated Unrealized Gains, Before Tax Cash And Cash Equivalents, Accumulated Unrealized Gains, Before Tax (Less): Accumulated amortization Intangible Asset, Finite-Lived, Accumulated Amortization Level 2 Fair Value, Inputs, Level 2 [Member] Other income (expense): Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Credit facility, aggregate principal amount Line of Credit Facility, Maximum Borrowing Capacity Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Revenue Benchmark Revenue Benchmark [Member] Contractual milestone payment net sales Collaborative Arrangement, Rights And Obligations, Contractual Milestone, Net Sales Collaborative Arrangement, Rights And Obligations, Contractual Milestone, Net Sales Subsequent Event Type [Axis] Subsequent Event Type [Axis] Issuance of common stock upon the vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Concentration Risk Type [Axis] Concentration Risk Type [Axis] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Recently Issued or Effective Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Additions of property and equipment included within accounts payable and other accrued liabilities Capital Expenditures Incurred but Not yet Paid Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Amortization of debt issuance costs Amortization of Debt Issuance Costs Use of Estimates Use of Estimates, Policy [Policy Text Block] Related Party [Axis] Related and Nonrelated Parties [Axis] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Exercise price per warrant (usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Long-term debt, net Long-Term Debt Pharmakon Credit Facility, Tranche One Pharmakon Credit Facility, Tranche One [Member] Pharmakon Credit Facility, Tranche One Schedule of Future Contractual Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Document Period End Date Document Period End Date Common stock awards reserved for future issuance under 2020 and 2016 Plans (in shares) Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Milestone Determined by the Company Milestone Determined by the Company [Member] Milestone Determined by the Company Number of leases Lessee, Operating Lease, Number Of Lease Contracts Lessee, Operating Lease, Number Of Lease Contracts Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Unrecognized tax benefits Unrecognized Tax Benefits Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Earnings Per Share, Basic [Abstract] Earnings Per Share, Basic [Abstract] Security Exchange Name Security Exchange Name Effective interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Granted (usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Additional cash payment Revenue, Remaining Performance Obligation, Additional Cash Payment Revenue, Remaining Performance Obligation, Additional Cash Payment Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Operating lease liability, current Operating Lease, Liability, Current Schedule of Property and Equipment, Net Property, Plant, and Equipment [Table Text Block] NET LOSS PER SHARE Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings Per Share [Abstract] Earnings Per Share [Abstract] Proceeds from maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol 2023 ATM Prospectus 2023 ATM Prospectus [Member] 2023 ATM Prospectus Schedule of Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Follow-On Public Offering Follow-On Public Offering [Member] Follow-On Public Offering Income Tax Disclosure [Abstract] Amortization of debt-related costs Amortization of Debt Issuance Costs and Discounts Unrealized gain (loss) on marketable securities and cash equivalents OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Supplemental Disclosures From Noncash, Investing and Financing Activities: Noncash Investing and Financing Items [Abstract] Unvested Share-Based Compensation Arrangement By Share-based Payment Award, Options, Nonvested, Aggregate Intrinsic Value Share-Based Compensation Arrangement By Share-based Payment Award, Options, Nonvested, Aggregate Intrinsic Value Long-term debt, gross Long-Term Debt, Gross Amortized cost Equity Securities, FV-NI, Cost Other accrued liabilities Increase (Decrease) in Other Accrued Liabilities Rent abatement Incentive from Lessor Related Party Transactions [Abstract] Cash Flows From Operating Activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Other receivables Other Receivables, Net, Current Upfront payment received Collaborative Arrangement, Rights And Obligations, Upfront Payment Collaborative Arrangement, Rights And Obligations, Upfront Payment Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Pre-funded warrants reserved for future issuance (in shares) Class of Warrant Or Right, Reserved for Future Issuance Class of Warrant Or Right, Reserved for Future Issuance Weighted-average shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted iRenix Medical, Inc. iRenix Medical, Inc. [Member] iRenix Medical, Inc. Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Pharmakon Credit Facility Pharmakon Credit Facility [Member] Pharmakon Credit Facility Useful lives of assets (in years) Property, Plant, and Equipment, Useful Life Underlying Security Market Price Change Underlying Security Market Price Change, Percent Draw on credit facility Proceeds from Lines of Credit Commercial paper Commercial Paper [Member] U.S. Treasury securities US Treasury Securities [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] (Less): Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Other non-current assets Increase (Decrease) in Other Noncurrent Assets Future cash payments Collaborative Arrangement, Future Cash Payments Collaborative Arrangement, Future Cash Payments Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash paid for our current lease Operating Lease, Payments Award Timing Predetermined Award Timing Predetermined [Flag] Restricted cash Restricted Cash, Current Debt Securities, Available-for-Sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Recognition of stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] State State and Local Income Tax Expense (Benefit), Continuing Operations Organization, Consolidation and Presentation of Financial Statements [Abstract] Total future lease payments, undiscounted Lessee, Operating Lease, Liability, to be Paid Square feet of office space Area of Real Estate Property Marketable securities: Debt Securities, Available-for-Sale [Abstract] Outstanding, beginning balance (usd per share) Outstanding, ending balance (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Intangible Assets, Net Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] All Executive Categories All Executive Categories [Member] Government-related debt securities US Government Debt Securities [Member] Commercial Sales Milestone Payments Commercial Sales Milestone Payments [Member] Commercial Sales Milestone Payments Unvested (in years) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (usd per share) Preferred Stock, Par or Stated Value Per Share Depreciation Depreciation Plan Name [Domain] Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Achievement Of First Commercial Sale Achievement Of First Commercial Sale [Member] Achievement Of First Commercial Sale Beginning balance (usd per share) Ending balance (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Selling and marketing Selling and Marketing Expense Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Concentration Risk Type [Domain] Concentration Risk Type [Domain] Schedule of Computation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Accumulated amortization of debt issuance costs Accumulated Amortization, Debt Issuance Costs Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] SEGMENT REPORTING Segment Reporting [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Schedule of Intangible Assets, Net Intangible Asset, Finite-Lived, Amortization Expense [Table Text Block] Income Statement Location [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Money market funds Total cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Upon Execution of the Novation Agreement Upon Execution of the Novation Agreement [Member] Upon Execution of the Novation Agreement Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Laboratory equipment Other Machinery and Equipment [Member] Proceeds from issuance of common stock, net of paid issuance costs Proceeds from Issuance of Common Stock Common stock, authorized (in shares) Common Stock, Shares Authorized Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Initial useful life (in years) Intangible Asset, Finite-Lived, Useful Life Deferred Tax Asset, Valuation Allowance [Table] Deferred Tax Asset, Valuation Allowance [Table] LianBio LianBio [Member] LianBio Stock issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Exercise Price Award Exercise Price Cash Flows From Investing Activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Remaining lease term (years) Lessee, Operating Lease, Remaining Lease Term Related Party Transaction [Axis] Related Party Transaction [Axis] Segment Reporting [Line Items] Segment Reporting [Line Items] Restricted stock units issued and outstanding (unvested) under the 2020 Plan (in shares) Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Property and Equipment, Net Property, Plant, and Equipment [Policy Text Block] CREDIT FACILITY AGREEMENT Debt Disclosure [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Other receivables Increase (Decrease) in Other Receivables Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Stock issued, net proceeds Sale of Stock, Consideration Received on Transaction Total operating expenses Costs and Expenses Adoption Date Trading Arrangement Adoption Date Inventory Inventory, Policy [Policy Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Number of securities with contractual maturity between one and three years Debt Securities, Available-for-Sale, Contractual Maturities Greater Than Twelve Months, Number of Securities Debt Securities, Available-for-Sale, Contractual Maturities Greater Than Twelve Months, Number of Securities Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Total other income (expense), net Nonoperating Income (Expense) ASSETS Assets: Assets [Abstract] Interest rate floor (as a percent) Debt Instrument, Floor Interest Rate Debt Instrument, Floor Interest Rate Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Total consideration for the transaction (in shares) Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares Amortized cost Amortized cost Debt Securities, Available-for-Sale, Amortized Cost Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Weighted-average risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Aggregate milestone payments upon achievement Business Combination, Contingent Consideration, Milestone Payment, Amount Business Combination, Contingent Consideration, Milestone Payment, Amount Present value of operating lease payments Total operating lease liability Operating Lease, Liability Issuance of common stock, net of issuance costs Payments of Stock Issuance Costs Insider Trading Policies and Procedures [Line Items] Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Performance Stock Unit Activity Performance Shares [Member] Selling, general and administrative General and administrative Selling, General and Administrative Expense BALANCE SHEET ACCOUNT DETAIL Supplemental Balance Sheet Disclosures [Text Block] Business Combination [Domain] Business Combination [Domain] COMMITMENTS & CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Grandpharma Grandpharma [Member] Grandpharma Outstanding and potentially dilutive securities excluded from computation of diluted net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Restricted Stock Unit Activity Restricted Stock Units (RSUs) [Member] Schedule of Outstanding Potentially Dilutive Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key Bobak Azamian Bobak Azamian [Member] Bobak Azamian Elizabeth Yeu-Lin [Member] Elizabeth Yeu-Lin (Less): Accumulated depreciation Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Alkeus Pharmaceuticals, Inc. Alkeus Pharmaceuticals, Inc. [Member] Alkeus Pharmaceuticals, Inc. Business Combination [Axis] Business Combination [Axis] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Income Taxes Income Tax, Policy [Policy Text Block] Net cash provided by (used in) operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Accounts Receivable Accounts Receivable [Member] Foreign Foreign Income Tax Expense (Benefit), Continuing Operations Income Statement [Abstract] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Shares issued in connection with the employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Gain on exchange of long-term investments Gain on exchange of long-term investments Gain (loss) on investments Gain (Loss) on Investments Operating expenses: Operating expenses: Operating Expenses [Abstract] Schedule of Federal, State and Foreign Income Tax Provision (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule of Valuation Assumptions of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Net proceeds Proceeds from (Repayments of) Debt Basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Spouse Of Ms. Yeu-Lin [Member] Spouse Of Ms. Yeu-Lin Development and Regulatory Milestone Development And Regulatory Milestone [Member] Development And Regulatory Milestone Accrued product sales deductions Accrued Sales Commission, Current City Area Code City Area Code Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Warrant issue price (usd per share) Class of Warrant or Right, Price Per Share Class of Warrant or Right, Price Per Share All Individuals All Individuals [Member] SUBSEQUENT EVENTS Subsequent Events [Text Block] Commercial and Sales Milestones Commercial And Sales Milestones [Member] Commercial And Sales Milestones Name Forgone Recovery, Individual Name Finished goods Inventory, Finished Goods, Net of Reserves Unrecognized compensation expense, weighted average period of recognition (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted-Average Grant Date Fair Value ($) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Consideration on equity interest Business Combination, Consideration Transferred, Equity Interest Statement [Line Items] Statement [Line Items] Total assets Assets Entity [Domain] Entity [Domain] Amounts Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Accounts Receivable, Net Accounts Receivable [Policy Text Block] Preferred stock, issued (in shares) Preferred Stock, Shares Issued Total shares of common stock reserved (in shares) Common Stock, Capital Shares Reserved for Future Issuance Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Interest expense Interest expense Interest Expense, Nonoperating Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Intangible Assets, Milestone Payment Intangible Assets, Milestone Payment [Member] Intangible Assets, Milestone Payment Weighted- Average Remaining Contractual Term (Years) Share-based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract] Share-based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Shares issued in connection with the employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Aggregate Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value Issuance of common stock, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Other accrued liabilities Other accrued liabilities Accounts Payable and Other Accrued Liabilities, Current PEO PEO [Member] Common stock votes Common Stock, Number Of Votes Common Stock, Number Of Votes Prepaid expenses Increase (Decrease) in Prepaid Expense Total stock-based compensation Share-Based Payment Arrangement, Expense Marketable securities Marketable Securities, Current Other long-term liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Exercise of vested stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Stock options issued and outstanding (unvested and vested) under the 2020 and 2016 Plans (in shares) Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding Granted (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Subsequent Event Type [Domain] Subsequent Event Type [Domain] Operating lease liability, non-current Operating Lease, Liability, Noncurrent Income tax payable, current Taxes Payable, Current Accumulated Deficit Retained Earnings [Member] Money market funds Money Market Funds [Member] Forfeited (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Schedule of Financial Instruments Measured at Fair Value Fair Value, by Balance Sheet Grouping [Table Text Block] Corporate debt securities Corporate Debt Securities [Member] Net loss per share - diluted (usd per share) Earnings Per Share, Diluted Accrued royalty payable Accrued Royalty Payable, Current Accrued Royalty Payable, Current Entity Current Reporting Status Entity Current Reporting Status License Agreement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Two Customers Two Customers [Member] Two Customers Accrued payroll and benefits Increase (Decrease) in Employee Related Liabilities Amortization of intangible assets Amortization expense Intangible Asset, Finite-Lived, Amortization Expense Research and development Research and development Research and Development Expense Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Share-Based Payment Arrangement [Abstract] Revenue recognized Revenue from Contract with Customer, Excluding Assessed Tax Cash Flows From Financing Activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Property and equipment, net Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Contractual maturity (in years) Debt Securities, Available-for-Sale, Term Financial Instruments [Domain] Financial Instruments [Domain] Exercise of vested stock options Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Intangible assets, gross Intangible Asset, Excluding Goodwill, before Accumulated Amortization Issuance of common stock, net of issuance costs Stock Issued During Period, Value, New Issues Underwriters' option Over-Allotment Option [Member] Prepaid expenses Prepaid Expense, Current Forfeited (usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Four Finite-Lived Intangible Asset, Expected Amortization, after Year Four Inventory Increase (Decrease) in Inventories Discount rate Operating Lease, Weighted Average Discount Rate, Percent Segment Reporting [Table] Segment Reporting [Table] Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Table] Sale of Stock [Axis] Sale of Stock [Axis] Schedule of Components of Lease Cost Lease, Cost [Table Text Block] Marketable Securities and Long-Term Investments Marketable Securities, Policy [Policy Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Office equipment Office Equipment [Member] Loss from operations before other income (expense) Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date Valuation Allowance by Deferred Tax Asset [Axis] Valuation Allowance by Deferred Tax Asset [Axis] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Related Party Transaction [Domain] Related Party Transaction [Domain] Sales-based Milestones Sales-Based Milestones [Member] Sales-based Milestones Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Business Combination, Contingent Consideration, Triggering Event [Axis] Business Combination, Contingent Consideration, Triggering Event [Axis] Business Combination, Contingent Consideration, Triggering Event Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Dr. Azamian and Dr. Link Private Company Transaction - Fair Value Of Preferred Units Dr. Azamian And Dr. Link Private Company Transaction - Fair Value Of Preferred Units [Member] Dr. Azamian And Dr. Link Private Company Transaction - Fair Value Of Preferred Units Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Pharmakon Credit Facility, Tranche Two Pharmakon Credit Facility, Tranche Two [Member] Pharmakon Credit Facility, Tranche Two Weighted- Average Exercise Price/Share ($) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] DESCRIPTION OF BUSINESS AND PRESENTATION OF FINANCIAL STATEMENTS Business Description and Basis of Presentation [Text Block] (Less): Tenant improvement allowance Lessee, Operating Lease, Liability, Tenant Improvement Allowance Lessee, Operating Lease, Liability, Tenant Improvement Allowance Long-Lived Assets Held-for-Sale by Asset Type [Axis] Long-Lived Asset, Held-for-Sale, Type [Axis] Equity Components [Axis] Equity Components [Axis] Accounts receivable, net Increase (Decrease) in Accounts Receivable Related Party Related Party [Member] Product and Service [Domain] Product and Service [Domain] Income taxes paid in cash Income Tax Paid, after Refund Received Reportable Segment Reportable Segment [Member] Reportable Segment Entity Interactive Data Current Entity Interactive Data Current Payments for tenant improvement allowance Payments for (Proceeds from) Tenant Allowance Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Debt issuance costs Debt Issuance Costs, Line of Credit Arrangements, Net Restricted stock units — unvested Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested [Member] Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested Entity Smaller Reporting Company Entity Small Business Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Termination Date Trading Arrangement Termination Date Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment [Line Items] Subsequent Events [Abstract] License fees and collaboration revenue License fees and collaboration revenue License And Collaboration [Member] License And Collaboration Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other liabilities Other Liabilities, Current Other assets Other Assets, Noncurrent Document Type Document Type Fair Value as of Grant Date Award Grant Date Fair Value SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES Significant Accounting Policies [Text Block] Available-for-sale Debt Securities, Contractual Maturity Less Than 12 Months Available-for-sale Debt Securities, Contractual Maturity Greater Than 12 Months [Member] Available-for-sale Debt Securities, Contractual Maturity Greater Than 12 Months Clinical Milestones Clinical Milestones [Member] Clinical Milestones Achievement Of Regulatory Approval For Gildeuretinol Achievement Of Regulatory Approval For Gildeuretinol [Member] Achievement Of Regulatory Approval For Gildeuretinol Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Impairments of intangible assets Intangible Asset, Excluding Goodwill, Impairment Loss Arrangement Duration Trading Arrangement Duration Subsequent Event [Line Items] Subsequent Event [Line Items] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Schedule of Performance Stock Unit Activity Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies (Note 8) Commitments and Contingencies Total revenues Total revenues Revenues Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Property and equipment, at cost Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] 2030 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four Manufacturing equipment Machinery and Equipment [Member] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Three Customers Three Customers [Member] Three Customers Counterparty Name [Axis] Counterparty Name [Axis] Furniture and fixtures Furniture and Fixtures [Member] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Inventory Inventory Inventory, Net Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount 2026 (remaining six months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Unvested (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One Lease term (in years) Lessee, Operating Lease, Term of Contract PEO Name PEO Name Leasehold improvements Leasehold Improvements [Member] Upfront payment Contract with Customer, Liability Other reconciling items Segment Reporting, Other Segment Item, Amount Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Axis] Concentration Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Legal Entity [Axis] Legal Entity [Axis] Total interest expense Interest Expense, Debt Common stock awards reserved for future issuance under the 2020 ESPP (in shares) Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan Exercised (usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Revenue Recognition Revenue [Policy Text Block] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Elanco Elanco [Member] Elanco Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt securities, available for sale and cash and cash equivalents Debt Securities, Available-For-Sale And Cash And Cash Equivalents, Fair Value Disclosure Debt Securities, Available-For-Sale And Cash And Cash Equivalents, Fair Value Disclosure Cash consideration Payments to Acquire Businesses, Gross Subsequent Event [Table] Subsequent Event [Table] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Potential additional tranches Debt Instrument, Number Of Potential Additional Tranches Debt Instrument, Number Of Potential Additional Tranches 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two Total lease expense Lease, Cost Fair market value of common stock (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Authorized consideration Sale of Stock, Consideration Amount Authorized Sale of Stock, Consideration Amount Authorized Schedule of Principal Balance of the 2024 Credit Facility Schedule of Debt [Table Text Block] Employee Stock Purchase Plan Employee Stock [Member] Related party transaction, amount of transaction Related Party Transaction, Amounts of Transaction Customer [Domain] Customer [Domain] Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Net loss per share - basic (usd per share) Earnings Per Share, Basic Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Long-term debt, net Long-Term Debt, Excluding Current Maturities Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Upfront payment received Upfront Payment Upfront Payment Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Restricted cash, non-current Restricted Cash, Noncurrent Unvested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Non-current assets: Inventory, Noncurrent [Abstract] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Total marketable securities Corporate debt securities Debt Securities, Available-for-Sale Milestone payments to be achieved Revenue, Remaining Performance Obligation, Variable Consideration, Amount Revenue, Remaining Performance Obligation, Variable Consideration, Amount Operating lease expense Operating Lease, Cost Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Long-Lived Assets Held-for-Sale, Name [Domain] Long-Lived Assets Held-for-Sale, Name [Domain] Cover [Abstract] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Annual increase in rent (as a percent) Lessee, Operating Lease, Annual Rent Increase, Percent Lessee, Operating Lease, Annual Rent Increase, Percent Amounts Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity [Abstract] Interest expense for long-term debt Interest Expense, Debt, Excluding Amortization Concentration risk (as a percent) Concentration Risk, Percentage Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Equity Awards Adjustments Equity Awards Adjustments [Member] OUT-LICENSE AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Security deposit Security Deposit Liability 2023 Shelf Registration Statement 2023 Shelf Registration Statement [Member] 2023 Shelf Registration Statement Total liabilities and stockholders’ equity Liabilities and Equity Variable lease expense Variable Lease, Cost Interest income Interest income Interest Income, Other Stock Option Activity Stock options, unexercised — vested and unvested Share-Based Payment Arrangement, Option [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Related Party [Domain] Related and Nonrelated Parties [Domain] Plan Name [Axis] Plan Name [Axis] Tabular List, Table Tabular List [Table Text Block] Additional paid-in capital Additional Paid in Capital Schedule of Estimated Value of Cash, Cash Equivalents, Marketable Securities, and Equity Securities Unrealized Gain (Loss) on Investments [Table Text Block] Other income (expense), net Other Nonoperating Income (Expense) Valuation Allowance [Line Items] Valuation Allowance [Line Items] Dr. Azamian and Dr. Link Private Company Transaction - Preferred Stock Exchange Amount Dr. Azamian And Dr. Link Private Company Transaction - Preferred Stock Exchange Amount [Member] Dr. Azamian And Dr. Link Private Company Transaction - Preferred Stock Exchange Amount Weighted-average volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three Schedule of Other Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] 2026 (remaining six months) Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Name Awards Close in Time to MNPI Disclosures, Individual Name Pharmakon Credit Facility, Tranche Three Pharmakon Credit Facility, Tranche Three [Member] Pharmakon Credit Facility, Tranche Three Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Long-Lived Asset, Class [Domain] Long-Lived Asset, Class [Domain] Original issue price (usd per share) Sale of Stock, Price Per Share Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Other segment disclosures: Segment Reporting, Other Disclosure [Abstract] Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding Preferred Stock, Value, Issued Adjustment to Compensation: Adjustment to Compensation [Axis] Cost of Sales Cost of Goods and Service [Policy Text Block] One Customer One Customer [Member] One Customer Accounts payable Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Interest expense paid in cash Interest Paid, Excluding Capitalized Interest, Operating Activity Statement of Cash Flows [Abstract] Selling, General and Administrative Selling, General and Administrative Expenses, Policy [Policy Text Block] Schedule of Total Shares Reserved For Future Issuance Schedule of Stock by Class [Table Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total assets measured at fair value Assets, Fair Value Disclosure Name Measure Name INCOME TAXES Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Number of available-for-sale debt securities in gross unrealized loss position for less than one year Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Debt Instrument [Line Items] Debt Instrument [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Total consideration for the transaction Business Combination, Consideration Transferred Additional Paid-In Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Name Trading Arrangement, Individual Name Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Amortized cost Cash and Cash Equivalent Base rent expense Operating Lease, Expense Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Company Selected Measure Amount Company Selected Measure Amount Number of employment arrangements with executive officers Number Of Employment Arrangements With Executive Officers Number Of Employment Arrangements With Executive Officers Schedule of Operating Financial Results of Therapeutics Segment Segment Reporting, Reconciliation of Profit (Loss) by Segment to Consolidated [Table Text Block] Depreciation and amortization expense Depreciation, Depletion and Amortization Federal Federal Income Tax Expense (Benefit), Continuing Operations Entity Address, Address Line Two Entity Address, Address Line Two Shares transferred (in usd per share) Business Combination, Price Per Share Current assets: Current assets: Assets, Current [Abstract] Non-PEO NEO Non-PEO NEO [Member] Total inventory Inventory, Current And Noncurrent, Net Inventory, Current And Noncurrent, Net Entity Address, Address Line One Entity Address, Address Line One Vested (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Provision for income taxes Provision for income taxes Provision for income taxes Income Tax Expense (Benefit) Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Customer Concentration Risk Customer Concentration Risk [Member] Cost of sales Cost of sales Cost of Product and Service Sold Award Timing Method Award Timing Method [Text Block] Net increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Milestone payment aggregate amount Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Thereafter Lessee, Operating Lease, Liability, to be Paid, After Current Fiscal Year Lessee, Operating Lease, Liability, to be Paid, After Current Fiscal Year Statement [Table] Statement [Table] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Exercisable (usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Leases Lessee, Leases [Policy Text Block] Underwriter purchase option (in days) Sale of Stock, Underwriter Purchase Option, Term Sale of Stock, Underwriter Purchase Option, Term Unrealized (gain) loss from transactions denominated in a foreign currency Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Revenues: Revenues: Revenues [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]